(Q45732900)

English

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy

scientific article published in April 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 December 2017

Randomized clinical trial of long-term outcome after resection of hepatitis C virus-related hepatocellular carcinoma by postoperative interferon therapy (English)

1 reference

Europe PubMed Central

15 December 2017

Hepatitis C virus

1 reference

based on heuristic

inferred from title

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kubo S

1

1 reference

Europe PubMed Central

15 December 2017

Nishiguchi S

2

1 reference

Europe PubMed Central

15 December 2017

Hirohashi K

3

1 reference

Europe PubMed Central

15 December 2017

Tanaka H

4

1 reference

Europe PubMed Central

15 December 2017

Shuto T

5

1 reference

Europe PubMed Central

15 December 2017

Kinoshita H

6

1 reference

Europe PubMed Central

15 December 2017

language of work or name

0 references

publication date

1 April 2002

1 reference

Europe PubMed Central

15 December 2017

British Journal of Surgery

1 reference

Europe PubMed Central

15 December 2017

89

1 reference

Europe PubMed Central

15 December 2017

4

1 reference

Europe PubMed Central

15 December 2017

418-422

1 reference

Europe PubMed Central

15 December 2017

Effects of continuous hepatitis with persistent hepatitis C viremia on outcome after resection of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Risk factors for recurrence after resection of hepatitis C virus-related hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Randomised trial of effects of interferon-alpha on incidence of hepatocellular carcinoma in chronic active hepatitis C with cirrhosis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Effects of long-term postoperative interferon-alpha therapy on intrahepatic recurrence after resection of hepatitis C virus-related hepatocellular carcinoma. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Clinicopathological criteria for multicentricity of hepatocellular carcinoma and risk factors for such carcinogenesis.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Relationship between multicentric occurrence of hepatocellular carcinoma and histology of noncancerous hepatic tissue in patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

The interferons. Mechanisms of action and clinical applications

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Interferons alpha and beta down-regulate the expression of basic fibroblast growth factor in human carcinomas

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Interferon beta prevents recurrence of hepatocellular carcinoma after complete resection or ablation of the primary tumor-A prospective randomized study of hepatitis C virus-related liver cancer

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Prognostic factors after recurrence of resected hepatocellular carcinoma associated with hepatitis C virus

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Determinants of outcome of compensated hepatitis C virus-related cirrhosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Recombinant interferon-α in inoperable hepatocellular carcinoma: A randomized controlled trial

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1323.2001.02054.X

21 January 2018

Identifiers

10.1046/J.0007-1323.2001.02054.X

1 reference

https://api.fatcat.wiki/v0/release/pg26jupe7bgklp2nblkeb7ubtm

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_pg26jupe7bgklp2nblkeb7ubtm

1 reference

https://api.fatcat.wiki/v0/release/pg26jupe7bgklp2nblkeb7ubtm

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/pg26jupe7bgklp2nblkeb7ubtm

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45732900&oldid=2079046271"